Navigation Links
PLC Systems' RenalGuard to be Demonstrated at Cardiology Meetings in Germany and Israel
Date:4/13/2012

MILFORD, Mass., April 13, 2012 /PRNewswire/ -- PLC Systems Inc. (OTC: PLCSF), a company focused on innovative medical device technologies, today announced that its innovative RenalGuard System™ is being demonstrated at two major cardiology meetings: Jahrestagung der DGK, the 78th Annual Congress of the German Society of Cardiology, April 11-14, 2012 in Mannheim, Germany, and the 59th Annual Conference of the Israel Heart Society, April 16-17, 2012 in Tel-Aviv, Israel.  Both ACIST Medical Systems, PLC's distributor in Germany, and A.M.I. Technologies, its distributor in Israel, are exhibiting RenalGuard in their booths at the events, demonstrating its ease of use along with scientific data supporting its efficacy to potential customers.  More than 8,000 clinicians and professionals are expected to attend the two conferences.

Mark R. Tauscher, president and chief executive officer of PLC Systems, said, "These conferences are premier cardiovascular events in Germany and Israel, two major new markets for RenalGuard®.  RenalGuard is being displayed in both the ACIST and A.M.I. booths at these events, providing important exposure of our new technology to global knowledge leaders, and current and potential customers."

In March 2012, A.M.I. became the exclusive distributor of RenalGuard in Israel, and secured Ministry of Health approval to market and distribute RenalGuard in the country.  In October 2011, ACIST became the exclusive distributor of PLC's RenalGuard in Germany and France, the two largest countries in the European Union. 

About PLC Systems

PLC Systems Inc., headquartered in Milford, Mass., is a medical device company focused on innovative technologies for the cardiac and vascular markets. PLC's newest product, RenalGuard, has been developed to help prevent the onset of Contrast-Induced Nephropathy (CIN) in at-risk patients undergoing certain cardiac and vascular imaging procedures. The Product is CE-marked and is being marketed in Europe and selected countries around the world. Two investigator-sponsored European studies have demonstrated RenalGuard's effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by FDA.

This press release contains "forward-looking" statements. For this purpose, any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will" and similar expressions are intended to identify forward-looking statements. Our statements of our objectives are also forward-looking statements. While we may elect to update forward-looking statements in the future, we specifically disclaim any obligation to do so, even if our estimates change, and you should not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release. Actual results could differ materially from those indicated by such forward-looking statements as a result of a variety of important factors, including that we may not receive necessary regulatory approvals to market our RenalGuard product or that such approvals may be withdrawn, the U.S. clinical trial for RenalGuard may not be completed in a timely fashion, if at all, or, if this clinical trial is completed, it may not produce clinically significant or meaningful results, the RenalGuard product may not be commercially accepted, operational changes, the need for additional financing, competitive developments may affect the market for our products, regulatory approval requirements may affect the market for our products, and additional risk factors described in the "Forward Looking Statements" section of our Annual Report on Form 10-K for the year ended December 31, 2011, a copy of which is on file with the SEC.

PLC Systems, PLC Medical Systems, PLC, RenalGuard and RenalGuard Therapy are trademarks of PLC Systems Inc.

Contact:  Mary T. Conway
508-520-2545
mconway@plcmed.com 


'/>"/>
SOURCE PLC Systems Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Puritan Medical Products Company Launches New Diagnostic Collection and Transport Systems
2. Merit Medical Systems to Announce First Quarter 2012 Results on April 24, 2012
3. Berg Pharma Presents Key Findings in Cancer Systems Biology and Mitochondrial Metabolism at AACR Meeting
4. Psyche Systems Announces Availability of MicroPath, the First LIS for Microbiology
5. PLC Systems Reports Fourth Quarter and Full Year 2011 Results
6. Endo Announces Departure of American Medical Systems President
7. Frost & Sullivan: U.S. Nuclear Medicine and PET Imaging Systems Market Witnessed a Rebound in 2010, With PET Blazing the Trail
8. FDA Clears Expanded Compatibility for INOMAX® Drug-Delivery Systems
9. Psyche Systems Corporation and Aperio® Announce Availability of Their Fully Integrated Anatomic Pathology System
10. Argus Health Systems to Participate in NCPDP Focus Group
11. OxySure Systems Announces Supplier Agreement With Grainger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Md. , Jan. 18, 2017  Kratom ... the coffee family, are often used to prepare ... consumed by several million Americans annually to increase ... a natural remedy for minor aches and pains. ... effects is intended to assist FDA and DEA ...
(Date:1/18/2017)... , Jan. 18, 2017 Safe Rx LLC ... pharmacies based in Loveland, Colorado , ... (LPVs) in selected Good Day locations.     ... cost-effective alternative for secure storage," said Milton Cohen ... than the price of a cup of coffee, you ...
(Date:1/18/2017)... DIEGO , Jan. 18, 2017 ... solutions for cell and advanced therapies , has ... French biopharmaceutical company developing "tumor starvation" treatments for ... medical needs. Under the agreement, Invetech will develop ... based on Erytech,s proprietary ERYCAPS technology platform, which ...
Breaking Medicine Technology:
(Date:1/17/2017)... California (PRWEB) , ... January 17, 2017 , ... ... have a point of difference. Eden Activewear is a stand-out company for several ... are exclusively online and only manufacture on demand, this is called 'Agile' manufacturing ...
(Date:1/17/2017)... ... January 17, 2017 , ... Healthful Balance announces ... company, owned and operated by Ed Stroup, was created to offer the highest ... highest level of customer service. Healthful Balance products can be purchased online through ...
(Date:1/17/2017)... Grove Village, IL (PRWEB) , ... January 17, ... ... for musicians and music enthusiasts at the National Association of Music Merchants (NAMM) ... January 19 – 22, 2017. , Etymotic’s ER•4® has long been the gold ...
(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s ... honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD ... elite group of providers. , Produced by Zeltiq, CoolSculpting is approved by the ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from ... primary eye care practitioners on the latest breakthroughs in the prevention, diagnosis and ... Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer ...
Breaking Medicine News(10 mins):